VI
BLFS icon

Versor Investments’s BioLife Solutions BLFS Stock Holding History

Versor Investments’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,363
Closed -$331K – 650
2025
Q2 		$331K Sell
15,363
-3,237
-17% -$73K 0.06% 512
2025
Q1 		$425K Buy
+18,600
New +$490K 0.07% 458
2022
Q3 		– Sell
-26,300
Closed -$363K – 796
2022
Q2 		$363K Buy
26,300
+10,600
+68% +$156K 0.01% 589
2022
Q1 		$357K Buy
+15,700
New +$413K 0.01% 433

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Versor Investments's BLFS Position: Q3 2025 in Review

Versor Investments sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 15,363 shares — an estimated $331K sold.

Versor Investments first reported a position in BLFS in Q1 2022 and held it in 4 quarters. The position peaked at $425K in Q1 2025. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Versor Investments reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 15,363 BioLife Solutions shares in Q3 2025, an estimated $331K.
  • Versor Investments first reported a position in BioLife Solutions in Q1 2022 and held it in 4 quarters.
  • Versor Investments's BioLife Solutions position peaked at $425K in Q1 2025.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.